Today: 30 April 2026

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Social Security Surprise: No SSI Check on Nov. 1 – See Why Your Payment Arrives Early

Social Security Surprise: No SSI Check on Nov. 1 – See Why Your Payment Arrives Early

SSI recipients will receive their November 2025 payment on October 31, as November 1 falls on a weekend. Regular Social Security payments for retirees and disabled beneficiaries remain on their usual November dates. The Social Security Administration confirmed no delays despite the government shutdown. A 2.8% cost-of-living adjustment will raise average benefits by about $56 per month in 2026.
31 October 2025
Biotech Boom: Cabaletta Bio’s CAR-T Trial Sparks 40% Stock Surge

Biotech Boom: Cabaletta Bio’s CAR-T Trial Sparks 40% Stock Surge

Cabaletta Bio shares surged up to 46% on Oct. 31, closing at $3.61 after strong CAR-T therapy data, with trading volume hitting 35.7 million shares. Phase 1/2 results showed major improvements in myositis and systemic sclerosis, and durable lupus nephritis remissions. The company remains pre-revenue, holding $194.7 million cash as of June 30. Wall Street analysts mostly rate CABA a “Buy,” with targets averaging $13–15.
31 October 2025
··
FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy Stock Surges Amid AI Data-Center Boom – But Is It Worth the Hype?

FuelCell Energy closed at $7.73 on Oct. 30, down 5.5% for the day and off recent highs above $11. The stock is up about 2.6% year-to-date but remains 24% below its 52-week peak. Q3 FY2025 revenue nearly doubled to $46.7 million, though net loss widened to $91.9 million. Wall Street consensus rates FCEL a “Hold” with an average 12-month target near $8.78.
31 October 2025
··
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Rockets 51% on Obesity Pill Breakthrough and $1B Pharma Deal

Rani Therapeutics shares closed at $2.20 on Oct. 31, up 51.7% for the day, following a $1.09 billion collaboration deal with Chugai Pharma and a $60.3 million equity raise. Trading volume surged, with nearly 172 million shares changing hands Oct. 20. Founder Mir Imran bought 2.08 million shares Oct. 27. Wall Street analysts now rate RANI a “Strong Buy” with average price targets near $10–11.
31 October 2025
··
Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc (NASDAQ: QUBT) Stock Skyrockets on Massive Financing & AI Hype – Bubble or Breakthrough?

QUBT shares surged over 2,500% year-to-date, reaching $16.79 intraday on Oct. 31, 2025, after a $750 million at-market stock offering earlier in the month. The company, still pre-revenue, reported a $36 million Q2 loss on $61,000 in sales. Recent government contracts include NASA and NIST deals. Analyst targets range from $15 to $40, with warnings of a possible “hype bubble.”
31 October 2025
····
Comet 3I/ATLAS: The Interstellar “Ghost Comet” Haunting Our Solar System This Halloween

Comet 3I/ATLAS: The Interstellar “Ghost Comet” Haunting Our Solar System This Halloween

Comet 3I/ATLAS, discovered July 1, 2025, is the third known interstellar object to enter our solar system. It reached perihelion in late October inside Mars’ orbit and will pass Earth at a safe distance of about 1.8 AU in December. The comet is faint, only visible with telescopes, and shows a coma and tail. Observatories worldwide are tracking its rapid escape back into interstellar space.
31 October 2025
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta Platforms Stock Takes a Sharp Dive: What Shocked Investors on Oct. 30–31, 2025?

Meta shares closed at $657.87 on Oct. 31, down over 12% in two days after Q3 results showed record revenue but an 83% drop in net income due to a $15.93 billion tax charge. The company raised 2025 capex guidance to $70–72 billion and warned 2026 spending will be “notably larger” for AI. EU regulators are investigating possible Digital Services Act violations, risking fines up to 6% of revenue.
31 October 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Alphabet (Google) Stock Skyrockets on AI & Cloud Boom – Could $300 Be Next?

Alphabet shares traded near $275–280 on Oct 30–31, 2025, putting its market cap around $3 trillion and up 30% year-to-date. Q3 revenue reached $102.3 billion, net income rose 33% to $34.98 billion, and adjusted EPS beat forecasts at $3.10. Google Cloud revenue jumped 34% to $15.16 billion. The EU fined Google $3.45 billion for ad-tech monopoly, and antitrust probes continue in the U.S. and India.
31 October 2025
···
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Skyrockets in AI Cloud Craze – 70% Rally & Bullish Targets

Oracle shares traded near $264 on Oct. 31, up about 2.9% intraday, after a volatile drop from a September high of $345. Fiscal Q1 2026 revenue rose 12% to $14.93 billion, with cloud revenue up 28% to $7.2 billion. Oracle signed four multi-billion-dollar AI cloud contracts in Q1 and reaffirmed strong guidance. The company was tapped to build OpenAI’s “Stargate” data center in Michigan and is part of the group acquiring TikTok’s U.S. business.
31 October 2025
··
Chevron (CVX) Stock Rallies on $2B Pipeline Deal – Could $200 Be Next?

Chevron’s Next Big Move: CVX Stock Could Skyrocket on $55B Hess Deal & Low-Carbon Push

Chevron closed its $55 billion Hess acquisition in July 2025, adding Guyana assets, and sold $2 billion in Colorado pipelines in October. Q3 earnings beat forecasts with adjusted EPS of $1.85 and record production of 4.1 million boe/day. Shares traded at $153–154 on Oct. 31, yielding 4.5%. Analysts’ average 12-month target is $170, with most rating the stock a “Buy.”
31 October 2025
·····
Tiny Biotech INTENSITY THERAPEUTICS Stock Skyrockets on Cancer Therapy Breakthrough – Experts See Big Upside

Biotech Bombshell: Intensity Therapeutics (INTS) Surges Nearly 400% on Major Cancer Trial News

Shares of Intensity Therapeutics closed at $1.32 on Oct. 30, surging nearly 395% intraday after Phase 1/2 trial data for INT230-6 showed a 75% disease-control rate in metastatic cancer. Over a billion shares traded, dwarfing the usual volume. After-hours, the price fell to around $0.90. The company’s market cap remains under $65 million.
31 October 2025
··
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit (RDDT) Stock Soars 240% in 2025 – AI Ad Boom Fuels Rally but Is It Sustainable?

Reddit stock closed at about $199 on Oct. 31, up 90% year-over-year but down from its $282 September peak. Shares jumped 10% after Reddit reported Q3 revenue of $585 million, beating estimates, and raised Q4 guidance. The company is expanding AI ad tools and suing AI firms over content scraping. Wall Street remains bullish, with median 12-month targets near $230.
31 October 2025
···
Tech Titans Hit Stratospheric Highs: Apple & Microsoft Smash $4T, Nvidia Eyes $5T Amid AI Frenzy

Apple Stock Soars Past $4 Trillion: Record iPhone Sales and Bullish Forecasts Fuel Rally

Apple closed at $271.40 on Oct. 30, near its 52-week high, after reporting Q4 revenue of $102.5 billion and EPS of $1.85, both slightly above Wall Street estimates. Shares jumped 3.7% post-earnings and rose another 2% pre-market on Oct. 31, boosted by strong holiday-quarter guidance. Year-to-date, the stock is up about 8%, lagging other tech leaders. Market cap stands at roughly $4 trillion.
31 October 2025
··
Plug Power Stock Skyrocketed 170% on Hydrogen Hype – Now It’s Sliding: Can PLUG Rebound?

Plug Power Stock Soars 170% on Hydrogen Hype – Will the Rally Last? (Oct 31, 2025 Update)

Plug Power closed at $2.65 on Oct. 30, down 4% for the day and up about 65% year-to-date after a volatile run. In late October, the company signed a 2 GW electrolyzer deal in Uzbekistan and named José Luis Crespo as next CEO. Plug raised $370 million in new financing and secured a $1.66 billion DOE loan guarantee. Analysts remain cautious, with consensus price targets near current levels.
31 October 2025
··
Stocks Surge as Trump Eases China Tariff Threats – Fed Rate-Cut Hopes Ignite Rally

VOO ETF Rockets to Record Highs After Fed Rate Cut – Tech Surge Powers Rally, Analysts Weigh In

VOO closed at $625.24 on Oct 30, 2025, about 17% above its January level. Year-to-date return stands near 16–18%, matching the S&P 500. Despite strong inflows earlier in the year, early October saw $1 billion in weekly outflows as investors rotated to other funds. VOO holds $790–800 billion in assets and charges a 0.03% fee.
31 October 2025
········
Nvidia’s Meteoric October: $4 Trillion Milestone, Mega AI Deals, and Unstoppable Momentum

Nvidia Stock Skyrockets Amid AI Frenzy – Is $300 Next?

Nvidia shares traded at $202.89 on Oct. 31, 2025, valuing the company near $4.93 trillion after briefly hitting $5 trillion in late October. Q2 FY2026 revenue jumped 56% to $46.7 billion, with profit margins near 72%. Nvidia secured a $100 billion GPU deal with OpenAI and invested $2 billion in xAI. U.S. export controls have cut China sales to near zero, threatening up to 15% of revenue.
31 October 2025
···
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti (RGTI) Quantum Stock Skyrockets 5,000% – October 2025 News, Price & Analyst Report

Rigetti Computing shares surged nearly 50-fold in 2025, closing at $42.52 on Oct. 30, up 7.9% for the day after peaking at $56.34 mid-month. The rally followed a $5.8 million U.S. Air Force contract and $5.7 million in hardware orders. Market cap now stands at $15–18 billion on annual revenue of about $8–10 million. Most analysts rate the stock a “Buy,” but average targets remain far below current prices.
31 October 2025
·
US Antimony (UAMY) Stock Skyrockets on $245M Defense Deal – Is It Too Good to Be True?

U.S. Antimony (UAMY) Stock Rockets 1500% on $245M Pentagon Deal – Bubble or Buy?

U.S. Antimony won a five-year Pentagon contract worth up to $245 million to supply antimony ingots. Shares surged to $19.71 in October 2025 before falling to around $8.40–$9.00 amid heavy trading. The company raised $51 million in stock offerings and reported $64 million cash on hand. UAMY operates the only two antimony smelters in North America and expects 2025 revenue of about $50 million.
31 October 2025
··
1 … 204 205 206 207 208 … 369

Stock Market Today

  • Microsoft Gains Major Customer, Boosting Stock Prospects
    April 29, 2026, 10:14 PM EDT. Microsoft (MSFT) secured a significant new customer, marking a key development for investors. The stock traded up 1.19% on April 27, 2026, reflecting positive market sentiment. Parkev Tatevosian, CFA, and The Motley Fool hold positions in Microsoft, signaling strong confidence in the company's growth. Tatevosian's affiliation with The Motley Fool includes potential compensation for subscriber referrals, though his views remain independent. This customer acquisition highlights Microsoft's ongoing expansion and potential for stock appreciation, making it a noteworthy event for shareholders.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop